CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice:: Phenotype and possible role in autoreactivity

被引:24
|
作者
Lettesjö, H [1 ]
Burd, GP [1 ]
Mageed, RA [1 ]
机构
[1] Kennedy Inst Rheumatol, London W6 8LH, England
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 07期
关键词
D O I
10.4049/jimmunol.165.7.4095
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lupus disease is marked by B lymphocyte hyperactivity and the production of Abs to dsDNA. The production of these anti-dsDNA Abs is T lymphocyte dependent. However, it is not clear how CD4(+) T lymphocytes provide help for B lymphocytes to produce IgG anti-dsDNA Abs. One possible mechanism is suggested by studies showing that human patients with systemic lupus erythematosus and lupus mice have increased numbers of CD40 ligand (CD40L)(+) T and B lymphocytes. The results described in this study reveal that young, clinically healthy lupus-prone New Zealand Black x New Zealand White F-1 (BWF1) mice have naive CD4(+) T cells with preformed CD40L. These cells contribute to a brisk response to immunization and to the production of anti-dsDNA Abs. In vitro experiments revealed that CD4(+) T cells with preformed CD40L could, upon stimulation, provide antiapoptotic signals for B cells but could not induce proliferation or reduce activation threshold. These results suggest that the direct target cells for the effect of T cells with preformed CD40L in lupus may not be B lymphocytes.
引用
收藏
页码:4095 / 4104
页数:10
相关论文
共 50 条
  • [1] Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model
    Karpouzas, GA
    La Cava, A
    Ebling, FM
    Singh, RR
    Hahn, BH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (09) : 2489 - 2499
  • [2] Clinical and histopathological progression of lesions in lupus-prone (NZB x NZW) F1 mice
    Burnett, R
    Ravel, G
    Descotes, J
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2004, 56 (1-2) : 37 - 44
  • [3] CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice
    Foell, J
    Strahotin, S
    O'Neil, SP
    McCausland, MM
    Suwyn, C
    Haber, M
    Chander, PN
    Bapat, AS
    Yang, XJ
    Chiorazzi, N
    Hoffmann, MK
    Mittler, RS
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10): : 1505 - 1518
  • [4] Contribution of CD1 molecule in shaping the in vivo cytokine milieu in Lupus-prone NZB/NZW F1 mice
    Yang, JQ
    Liu, HZ
    van Kaer, L
    Singh, RR
    FASEB JOURNAL, 2001, 15 (05): : A1066 - A1066
  • [5] Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32)
    Werwitzke, S.
    Trick, D.
    Sondermann, P.
    Kamino, K.
    Schlegelberger, B.
    Kniesch, K.
    Tiede, A.
    Jacob, U.
    Schmidt, R. E.
    Witte, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 154 - 161
  • [6] Involvement of IFN-γ producing CD4+ PD-1+ T cells in lupus-prone NZB/W f1 mice
    Kasagi, Shimpei
    Kawano, Seiji
    Morinobu, Akio
    Hatachi, Saori
    Okazaki, Taku
    Tanaka, Yoshimasa
    Minato, Nagahiro
    Honjo, Tasuku
    Kumagai, Shunichi
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S845 - S845
  • [7] Defective pathways that generate effective CD8+suppressors characterize lupus-prone (NZB x NZW) F1 mice.
    Karpouzas, GA
    Singh, RR
    Ebling, FM
    Hahn, BH
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S198 - S199
  • [9] Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice
    Fujii, T.
    Iida, Y.
    Yomogida, M.
    Ikeda, K.
    Haga, T.
    Jikumaru, Y.
    Ninami, M.
    Nishimura, N.
    Kodera, Y.
    Inada, Y.
    Shirai, T.
    Hirose, S.
    Nishimura, H.
    GENES AND IMMUNITY, 2006, 7 (08) : 647 - 654
  • [10] Regulatory T cells inhibit autoantigen-specific CD4+ T cell responses in lupus-prone NZB/W F1 mice
    Rosenberger, Stefan
    Undeutsch, Reinmar
    Akbarzadeh, Reza
    Ohmes, Justus
    Enghard, Philipp
    Riemekasten, Gabriela
    Humrich, Jens Y.
    FRONTIERS IN IMMUNOLOGY, 2023, 14